Ask AI
ProCE Banner Activity

关于通过指南指导的药物治疗 (GDMT) 管理心肾代谢疾病的专家见解

Clinical Thought

了解慢性肾脏病和心力衰竭等心肾代谢疾病在病理生理学上的重叠之处,并掌握在临床实践中实施指南指导药物治疗的策略。

Released: December 15, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Target Audience

本倡议面向管理心肾代谢疾病患者的心脏科医生、内分泌科医生、肾脏科医生、内科医生、执业护士和医师助理。

Program Learning Goal

本计划的目标是提升学习者在慢性肾脏病患者治疗方面的知识和能力,以优化治疗效果。

Learning Objectives

Upon completion of this activity, participants should be able to:

  • 评估针对慢性肾脏病 (CKD) 和心力衰竭 (HF) 患者的新兴疗法的最新临床证据。

Faculty Disclosure

Erin D. Michos,医学博士、公共卫生硕士、美国心脏病学会会员 (FACC)、美国心脏协会会员 (FAHA)、美国超声心动图学会会员 (FASE)、美国预防心脏病学会会员 (FASPC)

Primary Author

Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC: consultant/advisor/speaker: Arrowhead, AstraZeneca, Bayer, Boehringer Ingelheim, Edwards Lifescience, Ionis, Lilly, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer.